Research Article
Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes
Table 4
Clinical characteristics and concentrations of Apolipoproteins in the AH of healthy controls and diabetic patients with non-apparent DR.
| | Healthy controls1 () | No apparent DR () | -value |
| | Age (years; ) | | | 0.34 | | Gender: | | | | | Females: (%) | 16 (94) | 11 (48) | 0.002 | | Duration of diabetes (years; ) | N/A | | N/A | | BMI () | | | 0.072 | | Dyslipidemia (; %) | 0 | 15 (65) | 0.0005 | | Hypertension (; %) | 0 | 17 (74) | 0.0005 | | Apolipoproteins(;(median; IQR 25 – 75) ng/ml) | | Apo AI |
(121; 59-265) |
(235; 93-801) | 0.08 | | Apo AII |
(59;24-120) |
(104; 40-293) | 0.12 | | Apo CI |
(31; 14-50) |
(42; 22-108) | 0.16 | | Apo CIII |
(1.2; 0.6-2.1) |
(2.2; 1.0-5.8) | 0.053 | | Apo D |
(22; 17-29) |
(29; 17-50) | 0.14 | | Apo E |
(75; 45-93) |
(79; 41-127) | 0.54 | | Apo H |
(337; 288-586) |
(484; 275-943) | 0.26 | | Apo J |
(384; 268-455) |
(564; 302-805) | 0.11 |
|
|
1 Definition of healthy controls: no underlying disease, no medication.
|
